Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Terbinafine hydrochloride by Moberg Pharma for Onychomycosis (Tinea Unguium): Likelihood of Approval
Terbinafine hydrochloride is under clinical development by Moberg Pharma and currently in Phase III for Onychomycosis (Tinea Unguium). According to...
Data Insights
Terbinafine hydrochloride by Moberg Pharma for Onychomycosis (Tinea Unguium): Likelihood of Approval
Terbinafine hydrochloride is under clinical development by Moberg Pharma and currently in Phase III for Onychomycosis (Tinea Unguium). According to...